Cargando…

Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen

BACKGROUND: Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen. CASE PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreyra, Cecilia, O’Brien, Daniel, Alonso, Beatriz, Al-Zomour, Abdulbasset, Ford, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027556/
https://www.ncbi.nlm.nih.gov/pubmed/29988565
http://dx.doi.org/10.1186/s13031-018-0161-1
_version_ 1783336639503794176
author Ferreyra, Cecilia
O’Brien, Daniel
Alonso, Beatriz
Al-Zomour, Abdulbasset
Ford, Nathan
author_facet Ferreyra, Cecilia
O’Brien, Daniel
Alonso, Beatriz
Al-Zomour, Abdulbasset
Ford, Nathan
author_sort Ferreyra, Cecilia
collection PubMed
description BACKGROUND: Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen. CASE PRESENTATION: In CAR, MSF has provided HIV care in three conflict-affected rural regions; these were put on hold throughout the acute phase of violence. “Run-away bags” containing 3 or 4 months of ART were distributed to patients at MSF facilities. Among 1820 HIV patients enrolled into care, 1440 (79%) initiated ART. By December 2016, 782 (54%) patients were still under ART, 354 (25%) have been lost to follow up and 182 (13%) had died. In 2013, when violence disrupted services, 683 patients were receiving ART. Between September–December 2013, 594 (87%) patients received runaway bags and by February 2014, 313 (53%) of these patients returned to the clinic. In Yemen, when violence erupted, patients received a health card that included a helpline to call in case of drug shortages in admission to emergency stocks; this was not possible in CAR due to lack of a functioning telephone network. One thousand six hundred fifty-five PLWHA have been enrolled in care and 1470 (89%) initiated ART; 1056 (72%) are still followed on ART, 126 (9%) were lost to follow up, and 288 (20%) died. In January 2011 clashes began and by April 2011 MSF medical activities were interrupted. Of the 363 patients receiving ART, 363 (100%) received emergency bags to cover 9 months and by February 2012, 354 (98%) patients returned to care. In March 2015 a new wave of conflict affected Yemen, forcing HIV activities to revert to contingency planning. CONCLUSIONS: This experience provides further evidence that provision of HIV treatment and emergency drug stocks can be successfully provided to most patients in both conflict-affected settings.
format Online
Article
Text
id pubmed-6027556
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60275562018-07-09 Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen Ferreyra, Cecilia O’Brien, Daniel Alonso, Beatriz Al-Zomour, Abdulbasset Ford, Nathan Confl Health Case Study BACKGROUND: Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen. CASE PRESENTATION: In CAR, MSF has provided HIV care in three conflict-affected rural regions; these were put on hold throughout the acute phase of violence. “Run-away bags” containing 3 or 4 months of ART were distributed to patients at MSF facilities. Among 1820 HIV patients enrolled into care, 1440 (79%) initiated ART. By December 2016, 782 (54%) patients were still under ART, 354 (25%) have been lost to follow up and 182 (13%) had died. In 2013, when violence disrupted services, 683 patients were receiving ART. Between September–December 2013, 594 (87%) patients received runaway bags and by February 2014, 313 (53%) of these patients returned to the clinic. In Yemen, when violence erupted, patients received a health card that included a helpline to call in case of drug shortages in admission to emergency stocks; this was not possible in CAR due to lack of a functioning telephone network. One thousand six hundred fifty-five PLWHA have been enrolled in care and 1470 (89%) initiated ART; 1056 (72%) are still followed on ART, 126 (9%) were lost to follow up, and 288 (20%) died. In January 2011 clashes began and by April 2011 MSF medical activities were interrupted. Of the 363 patients receiving ART, 363 (100%) received emergency bags to cover 9 months and by February 2012, 354 (98%) patients returned to care. In March 2015 a new wave of conflict affected Yemen, forcing HIV activities to revert to contingency planning. CONCLUSIONS: This experience provides further evidence that provision of HIV treatment and emergency drug stocks can be successfully provided to most patients in both conflict-affected settings. BioMed Central 2018-07-02 /pmc/articles/PMC6027556/ /pubmed/29988565 http://dx.doi.org/10.1186/s13031-018-0161-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Study
Ferreyra, Cecilia
O’Brien, Daniel
Alonso, Beatriz
Al-Zomour, Abdulbasset
Ford, Nathan
Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title_full Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title_fullStr Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title_full_unstemmed Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title_short Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title_sort provision and continuation of antiretroviral therapy during acute conflict: the experience of msf in central african republic and yemen
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027556/
https://www.ncbi.nlm.nih.gov/pubmed/29988565
http://dx.doi.org/10.1186/s13031-018-0161-1
work_keys_str_mv AT ferreyracecilia provisionandcontinuationofantiretroviraltherapyduringacuteconflicttheexperienceofmsfincentralafricanrepublicandyemen
AT obriendaniel provisionandcontinuationofantiretroviraltherapyduringacuteconflicttheexperienceofmsfincentralafricanrepublicandyemen
AT alonsobeatriz provisionandcontinuationofantiretroviraltherapyduringacuteconflicttheexperienceofmsfincentralafricanrepublicandyemen
AT alzomourabdulbasset provisionandcontinuationofantiretroviraltherapyduringacuteconflicttheexperienceofmsfincentralafricanrepublicandyemen
AT fordnathan provisionandcontinuationofantiretroviraltherapyduringacuteconflicttheexperienceofmsfincentralafricanrepublicandyemen